Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • November 2017
  • Case
  • HBS Case Collection

BeiGene

By: Willy Shih and Jimmy Zhang
  • Format:Print
  • | Language:English
  • | Pages:12
ShareBar

Abstract

BeiGene was a biopharmaceutical company founded on exploiting a temporal regulatory policy discontinuity. Because of regulatory challenges in China, most innovative new drugs launched there four to six years after their initial U.S. launches. This gave BeiGene a window of opportunity to develop drug candidates toward known targets with known mechanisms of actions that would allow it to become first-in-class in China. But how well would the company's strategy hold up to the 2017 regulatory reforms?

Keywords

Biotechnology; Pharmaceutical Company; Pharmaceuticals; China; Regulatory Environment; Business Strategy; Business Startups; Innovation Strategy; Situation or Environment; Pharmaceutical Industry; China

Citation

Shih, Willy, and Jimmy Zhang. "BeiGene." Harvard Business School Case 618-033, November 2017.
  • Educators
  • Purchase

About The Author

Willy C. Shih

Technology and Operations Management
→More Publications

Related Work

    • January 2018
    • Faculty Research

    BeiGene

    By: Willy Shih and Jimmy Zhang
    • January 2018
    • Faculty Research

    BeiGene Supplemental PowerPoint

    By: Willy C. Shih and Jimmy Zhang
Related Work
  • BeiGene By: Willy Shih and Jimmy Zhang
  • BeiGene Supplemental PowerPoint By: Willy C. Shih and Jimmy Zhang
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.